WO2012061536A3 - Méthodes de traitement de troubles capillaires - Google Patents
Méthodes de traitement de troubles capillaires Download PDFInfo
- Publication number
- WO2012061536A3 WO2012061536A3 PCT/US2011/059027 US2011059027W WO2012061536A3 WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3 US 2011059027 W US2011059027 W US 2011059027W WO 2012061536 A3 WO2012061536 A3 WO 2012061536A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- hair loss
- treating hair
- loss disorders
- treating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Cosmetics (AREA)
Abstract
L'invention concerne des méthodes de traitement de troubles capillaires chez un sujet par l'administration d'un inhibiteur de NKG2D, d'un inhibiteur d'IL-15 ou d'une combinaison de ceux-ci.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40951410P | 2010-11-02 | 2010-11-02 | |
US61/409,514 | 2010-11-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012061536A2 WO2012061536A2 (fr) | 2012-05-10 |
WO2012061536A3 true WO2012061536A3 (fr) | 2014-04-10 |
Family
ID=46025095
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/059027 WO2012061536A2 (fr) | 2010-11-02 | 2011-11-02 | Méthodes de traitement de troubles capillaires |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012061536A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102993097A (zh) * | 2012-11-09 | 2013-03-27 | 贵州大学 | 吡唑酰胺类化合物及其应用 |
US11845801B2 (en) | 2019-06-12 | 2023-12-19 | AskGene Pharma, Inc. | IL-15 prodrugs and methods of use thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080069791A1 (en) * | 2003-12-29 | 2008-03-20 | Universitaetsklinikum Muenster | Means for stimulation and activation of hair growth by il-15 |
-
2011
- 2011-11-02 WO PCT/US2011/059027 patent/WO2012061536A2/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080069791A1 (en) * | 2003-12-29 | 2008-03-20 | Universitaetsklinikum Muenster | Means for stimulation and activation of hair growth by il-15 |
Also Published As
Publication number | Publication date |
---|---|
WO2012061536A2 (fr) | 2012-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2012061537A3 (fr) | Méthodes de traitement de troubles capillaires | |
WO2014042433A3 (fr) | Composés et compositions de modulation de l'activité du récepteur adénosine a3 | |
WO2013046060A9 (fr) | Papier et procédés de fabrication du papier | |
PT2649242E (pt) | Processo para a construção de estruturas, nomeadamente passagens sob ferrovias em funcionamento ou similares | |
WO2014035140A3 (fr) | Composés et compositions pour la modulation de l'activité histone méthyltransférase | |
HK1193091A1 (en) | Substituted 3-(biphenyl-3-yl)-8,8-difluoro-4-hydroxy-1-azaspiro[4.5]dec-3- en-2-ones for therapy 3-(-3-)-88--4--1-[45]-3--2- | |
WO2013177055A3 (fr) | Anticorps et immunoconjugués anti-ly6e et procédés d'utilisation | |
WO2011142858A3 (fr) | Variants de la chlorotoxine, conjugués, et leurs méthodes d'utilisation | |
WO2012166626A8 (fr) | Réactifs et procédés pour traiter une maladie dentaire | |
WO2012103393A3 (fr) | Lutte contre les cochenilles | |
TN2010000096A1 (en) | Oxadiazole - and oxazole - substituted benzimidazole - and indole - derivatives as dgat1 inhibitors | |
WO2011133504A3 (fr) | Nanozymes, procédés de production de nanozymes, et procédés d'utilisation de nanozymes | |
WO2011075636A3 (fr) | Épitopes et agents de liaison destinés à wise | |
HK1193100A1 (zh) | 苯基- -氮雜-雙環 己- -基-甲酮及其作為藥物的用途 | |
EP2729464B8 (fr) | 1,3-thiazépines à cyclopropyle fusionné en tant qu'inhibiteurs de bace 1 et/ou de bace 2 | |
WO2011130347A3 (fr) | Procédés d'amélioration d'une régénération axonale | |
WO2013023151A3 (fr) | Compositions et méthodes de traitement de maladie cœliaque | |
WO2011083483A3 (fr) | Procédé pour traiter une maladie et un trouble inflammatoires | |
WO2012064743A3 (fr) | Procédés d'amélioration de la fonction cardiaque | |
WO2013016280A3 (fr) | Compositions et procédés pour sélectionner des aptamères | |
WO2012154533A3 (fr) | Lutte contre les fulgores | |
WO2011110624A3 (fr) | β-HYDROXYALKYLAMIDES, PROCÉDÉ POUR LES PRODUIRE ET LEUR UTILISATION | |
WO2011133893A3 (fr) | Antidotes du cyanure | |
WO2012061536A3 (fr) | Méthodes de traitement de troubles capillaires | |
WO2011011733A3 (fr) | Thérapie de remplacement de facteur |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11838770 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11838770 Country of ref document: EP Kind code of ref document: A2 |